ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Lundbeck trims full-year sales outlook as Northera generics bite firstwordpharma
August 19, 2021CEO Deborah Dunsire said growth of Lundbeck's strategic brands in the second-quarter has been accelerating post-pandemic, recording double-digit gains again "as we begin to see more normalised interaction between physicians and patients." -
Lupin gets US FDA approval for Droxidopa Capsules expresspharma
February 20, 2021Lupin announced that it has received approval for its Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, from the United States Food and Drug Administration, to market a generic equivalent of Northera Capsules, 100 mg, 200 mg, and 300 mg, of Lundbeck.
Pharma Sources Insight January 2025
